THYNK utilizes a patented EEG headset to provide real-time biofeedback while children engage with the video game Skylar’s Run, enhancing their cognitive skills related to focus and self-regulation. This approach has demonstrated an 80% improvement in attention-related symptoms among children with ADHD, significantly boosting their academic performance and behavioral control.
Funding
$7.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many children struggle with attention deficits, leading to difficulties in behavior, impulse control, and academic performance. Traditional interventions may not provide engaging or sustainable improvements in focus and self-regulation.
Solution
THYNK offers a digital therapeutic platform that uses real-time biofeedback to improve cognitive skills in children. The system combines a patented EEG headset with the video game Skylar’s Run to adaptively challenge and train the brain. By monitoring brainwaves, the game dynamically adjusts to the child's skill level, creating an optimal balance between challenge and skill to enhance focus and attention. Clinical trials have demonstrated significant improvements in attention-related symptoms and cognitive skills, offering a non-pharmaceutical approach to improving focus and self-regulation.
Target Audience
The primary audience includes parents of children with attention deficits, as well as young adults, professionals, athletes, and clinical patients seeking to improve focus and cognitive function.
Features
- Patented EEG headset that measures brainwaves to monitor attention and focus in real-time
- Skylar’s Run video game that dynamically adapts to the player's cognitive state
- Adaptive gameplay that balances skill and challenge to maintain an optimal flow state
- Training across 13 key cognitive skills, including focused attention, sustained attention, and cognitive inhibition
- Clinically proven to improve attention-related symptoms and cognitive skills
- Suitable for children, young adults, professionals, athletes, and clinical use
- Available on smartphone and tablet devices